REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChenavari Toro Regulatory News (TORO)

Share Price Information for Chenavari Toro (TORO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.52
Bid: 0.50
Ask: 0.54
Change: 0.005 (0.95%)
Spread: 0.04 (8.00%)
Open: 0.525
High: 0.53
Low: 0.53
Prev. Close: 0.525
TORO Live PriceLast checked at -
Chenavari Toro Income is an Investment Trust

To deliver an absolute return primarily investing and trading in ABS and other structured credit investments in liquid markets, and investing in asset backed transactions including through the origination of credit portfolios.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Brexit Impact on Toro Limited

27 Jun 2016 17:00

RNS Number : 3978C
Toro Limited
27 June 2016
 

Toro Limited

27 June 2016

Brexit impact on Toro Limited

 

The Portfolio Manager would like to share their first thoughts with Toro Limited ("Toro" or the "Company") investors as to the impact of the "Brexit" vote on the European ABS market and performance of the Toro portfolio, as well as the potential consequences of Brexit on the strategy.

 

Initial impact on the European ABS market and Toro performance

Following an initial sharp sell-off in risky assets, the European credit market rebounded as Friday morning progressed (iTraxx Xover retraced 50bps from the intra-day wide levels of 450bps). The European ABS market was rather calm and orderly with decent buying inquiries across the spectrum initially and no forced sellers in sight. Indeed, bottom fishers emerged and bids across the stack improved to clear on the following levels: UK non-conforming senior RMBS at a discount margin of 210bps (+50bps), BBB CLO 2.0 tranches traded at a discount margin of 475bps (+75bps) and Spanish high beta senior RMBS at a discount margin of 475bps (+100bps) just to name a few.

Therefore, benchmarking Toro's positions to these levels and extrapolating for other sectors, we would expect the Company's exposure to Public ABS to be marked down by 3% (gross estimate subject to revisions). Public ABS represented 61.7% of the NAV as at 31 May 2016.

On the Private Asset Backed Finance strategy, exposure to CLO warehouse will also be marginally marked down although offers on leveraged loans in performing high quality credits remained at or above par as there were few forced sellers and ample cash positions within recently printed CLOs.

Toro's large cash position (22%), low leverage ratio (78%) and hedging policy reflected a defensive positioning that we have been advocating for months, ahead of this binary event. Such mitigating factors are likely to offset the mark-to-market losses and Toro's NAV is expected to be marginally down month-to-date (-1% to 0%).

 

Consequences of Brexit on the strategy

Clearly, the capacity of the Portfolio Manager to assess the impact of Brexit is limited until a post-Brexit trajectory is agreed by the UK and the EU or at least proposed by the incoming Prime Minister. There is a lot of uncertainty ahead, but also some offsetting factors such as policy responses from central banks and political bodies in the UK and abroad that would dampen expected market volatility.

Brexit is likely to harm the UK economy first as both investments and consumption wane. A mild recession could be accompanied by falling real estate prices, increasing arrears and default rates affecting directly UK consumer ABS transactions. Exposure to UK assets in Toro (especially non-conforming and buy-to-let RMBS) was reduced significantly in Q1 2016. The Portfolio Manager has stress tested the remaining 6.5% of UK RMBS exposure and expects no losses under such a scenario. Indirect exposure to UK corporate through the CLOs is 2.2% and benefits from limited exposure to domestic consumer risk.

The overall European economy is also expected to be impacted and, although the current short term outlook remains benign and technically supported by the ECB's accommodative stance, the UK referendum could trigger further political instability in the EU. Therefore, the Portfolio Manager expects to continue to manage actively tail risk hedges. Both mortgage loan origination in Europe and Leveraged loans CLO formation are also likely to slowdown, potentially delaying the implementation of the origination strategy.

The increase degree of risk aversion in the market is also likely to last, as uncertainty from a Brexit should remain in place for an extended period of time given the complexity and duration of the process. A calm and opportunistic approach to investment, made possible by Toro's capital structure, should create better entry points both on liquid and illiquid assets as markets adjust to the new reality.

 

 

Enquiries:

Kirstie McLaren

Chenavari Investment Managers

Email: tlir@chenavari.com

Telephone: +44 207 259 3600

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUBUVRNSANUAR
Date   Source Headline
1st May 20247:00 amRNSCompany Factsheet Available
30th Apr 20247:00 amRNSDividend Declaration
29th Apr 20245:00 pmRNSNet Asset Value(s)
2nd Apr 20247:00 amRNSTotal Voting Rights
28th Mar 20245:00 pmRNSCompany Factsheet Available
27th Mar 20245:00 pmRNSNet Asset Value(s)
8th Mar 20241:00 pmRNSResult of AGM
7th Mar 20245:00 pmRNSShares in Issue
29th Feb 20247:00 amRNSCompany Factsheet Available
26th Feb 20245:00 pmRNSNet Asset Value(s)
15th Feb 20245:00 pmRNSScrip Dividend Election Price
8th Feb 20247:00 amRNSNotice of AGM
31st Jan 20247:00 amRNSCompany Factsheet Available
30th Jan 20247:01 amRNSQuarterly Investor Webinar
30th Jan 20247:00 amRNSDividend Declaration
25th Jan 20247:00 amRNSNet Asset Value(s)
5th Jan 20247:00 amRNSCompany Factsheet Available
2nd Jan 20247:00 amRNSTotal Voting Rights
28th Dec 20237:00 amRNSAnnual Report and Audited Financial Statements
22nd Dec 20237:01 amRNSShares in Issue
18th Dec 20237:00 amRNSNet Asset Value(s)
8th Dec 20235:00 pmRNSShares in Issue
29th Nov 20237:00 amRNSCompany Factsheet Available
22nd Nov 202310:30 amRNSNet Asset Value(s)
16th Nov 20235:00 pmRNSScrip Dividend Election Price
3rd Nov 20237:05 amRNSQuarterly Investor Webinar
27th Oct 20235:00 pmRNSCompany Factsheet Available
27th Oct 20237:00 amRNSDividend Declaration
26th Oct 20237:00 amRNSNet Asset Value(s)
2nd Oct 20237:00 amRNSTotal Voting Rights
29th Sep 20237:00 amRNSCompany Factsheet Available
21st Sep 20235:00 pmRNSNet Asset Value(s)
8th Sep 20235:00 pmRNSShares in Issue
29th Aug 20237:00 amRNSCompany Factsheet Available
21st Aug 20235:00 pmRNSNet Asset Value(s)
17th Aug 20235:00 pmRNSScrip Dividend Election Price
28th Jul 20237:00 amRNSDividend Declaration
27th Jul 20237:00 amRNSCompany Factsheet Available
21st Jul 20237:00 amRNSNet Asset Value(s)
3rd Jul 20237:00 amRNSTotal Voting Rights
30th Jun 20237:00 amRNSCompany Factsheet Available
28th Jun 20235:00 pmRNSInterim Financial Statements
22nd Jun 202311:00 amRNSNet Asset Value(s)
9th Jun 20235:00 pmRNSShares in Issue
1st Jun 20237:00 amRNSCompany Factsheet Available
23rd May 20235:45 pmRNSNet Asset Value(s)
18th May 20235:00 pmRNSScrip Dividend Election Price
28th Apr 20235:00 pmRNSCompany Factsheet Available
28th Apr 20237:01 amRNSDirectorate Change
28th Apr 20237:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.